<SEC-DOCUMENT>0001193125-15-346851.txt : 20151224
<SEC-HEADER>0001193125-15-346851.hdr.sgml : 20151224
<ACCEPTANCE-DATETIME>20151019145157
<PRIVATE-TO-PUBLIC>
ACCESSION NUMBER:		0001193125-15-346851
CONFORMED SUBMISSION TYPE:	CORRESP
PUBLIC DOCUMENT COUNT:		4
FILED AS OF DATE:		20151019

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			NUVEEN DIVIDEND ADVANTAGE MUNICIPAL INCOME FUND
		CENTRAL INDEX KEY:			0001090116
		IRS NUMBER:				752998730
		STATE OF INCORPORATION:			MA
		FISCAL YEAR END:			1031

	FILING VALUES:
		FORM TYPE:		CORRESP

	BUSINESS ADDRESS:	
		STREET 1:		NUVEEN INVESTMENTS
		STREET 2:		333 WEST WACKER DRIVE
		CITY:			CHICAGO
		STATE:			IL
		ZIP:			60606
		BUSINESS PHONE:		3129178146

	MAIL ADDRESS:	
		STREET 1:		NUVEEN INVESTMENTS
		STREET 2:		333 WEST WACKER DRIVE
		CITY:			CHICAGO
		STATE:			IL
		ZIP:			60606

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NUVEEN INSURED DIVIDEND ADVANTAGE MUNICIPAL FUND
		DATE OF NAME CHANGE:	19990709
</SEC-HEADER>
<DOCUMENT>
<TYPE>CORRESP
<SEQUENCE>1
<FILENAME>filename1.htm
<TEXT>
<HTML><HEAD>
<TITLE>Nuveen Dividend Advantage Municipal Income Fund</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" ALIGN="center">


<TR>
<TD WIDTH="34%"></TD>
<TD VALIGN="bottom"></TD>
<TD WIDTH="33%"></TD>
<TD VALIGN="bottom"></TD>
<TD WIDTH="31%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:6.5pt">
<TD VALIGN="top">


<IMG SRC="g95583im1.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ROWSPAN="2"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8.5pt; font-family:Times New Roman"><FONT STYLE="font-family:ARIAL">222 NORTH LASALLE STREET</FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8.5pt; font-family:Times New Roman"><FONT STYLE="font-family:ARIAL">CHICAGO, ILLINOIS 60601</FONT></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8.5pt; font-family:Times New Roman"><FONT
STYLE="font-family:ARIAL">T: +1 (312) 609 7500</FONT></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8.5pt; font-family:Times New Roman"><FONT STYLE="font-family:ARIAL">F: +1 (312) 609 5005</FONT></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:6.5pt; font-family:Times New Roman">CHICAGO &#149; NEW YORK &#149; WASHINGTON, DC</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:6.5pt; font-family:Times New Roman">LONDON &#149; SAN FRANCISCO &#149; LOS ANGELES</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:12pt">
<TD VALIGN="top"> <P STYLE="font-size:24pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman">JACOB C. TIEDT</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman">ATTORNEY AT LAW</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman">+1 (312)&nbsp;609 7697</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Times New Roman">jtiedt@vedderprice.com</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:24pt; margin-bottom:0pt; margin-left:56%; font-size:12pt; font-family:Times New Roman" ALIGN="center">October&nbsp;19, 2015 </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">U.S. Securities and Exchange Commission </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">Division of Investment
Management </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">100 F Street, N.E. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">Washington, D.C. 20549 </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">Attn:</TD>
<TD ALIGN="left" VALIGN="top">&nbsp;&nbsp;&nbsp;&nbsp;Deborah Skeens </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">&nbsp;&nbsp;&nbsp;&nbsp;Senior Counsel </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="94%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt">


<TR>
<TD WIDTH="3%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="79%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="16%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:12pt">
<TD VALIGN="top">Re:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">Nuveen Dividend Advantage Municipal Income Fund</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">(the &#147;Registrant&#148; or the &#147;Acquiring Fund&#148;);</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:12pt; font-family:Times New Roman"><U>File No.
333-206627&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">To the Commission: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">On behalf of the Registrant, this letter is in response to the comments provided telephonically by the staff of the U.S.
Securities and Exchange Commission (the &#147;Commission&#148;) to Vedder Price P.C. on October&nbsp;9, 2015, with respect to Pre-Effective Amendment No.&nbsp;1 to the Registrant&#146;s Registration Statement on Form N-14 filed on October&nbsp;2,
2015 (the &#147;Registration Statement&#148;) relating to the issuance of common shares in connection with the proposed reorganizations of Nuveen Quality Municipal Fund, Inc. (&#147;Quality Municipal&#148;), Nuveen Quality Income Municipal Fund,
Inc. (&#147;Quality Income&#148;) and Nuveen Municipal Opportunity Fund, Inc. (&#147;Municipal Opportunity&#148; and together with Quality Municipal and Quality Income, the &#147;Target Funds&#148; and each individually, a &#147;Target Fund&#148;)
into the Acquiring Fund (each, a &#147;Reorganization&#148; and together, the &#147;Reorganizations&#148;). The Acquiring Fund and the Target Funds are referred to herein each as a &#147;Fund&#148; and collectively as the &#147;Funds.&#148; Any
terms not defined herein have the same meanings as given in the Registration Statement. Set forth below are the staff&#146;s comments and the Registrant&#146;s responses. The Registrant filed Pre-effective Amendment No.&nbsp;2 to the
Registrant&#146;s Registration Statement on Form&nbsp;N-14 on October 16, 2015 to address the comments of the staff. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"><B><I>Comment:</I></B> &nbsp;&nbsp;&nbsp;&nbsp;Please correct the reference to the powers of attorney referred to on the Exhibit List included in Part&nbsp;C as being &#147;filed herewith.&#148; </TD></TR></TABLE>
<P STYLE="font-size:24pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g95583im2.jpg" ALT="LOGO">
 </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g95583im3.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">U.S. Securities and Exchange Commission </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">October 19, 2015 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"> Page
 2
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:15%; font-size:12pt; font-family:Times New Roman" ALIGN="justify"><B><I>Response: </I></B>&nbsp;&nbsp;&nbsp;&nbsp;The powers of attorney were
filed as exhibits to the Registrant&#146;s initial Registration Statement on Form&nbsp;N-14 on August&nbsp;27, 2015 and are incorporated by reference. The Registrant has corrected the reference in the Exhibit List in Part&nbsp;C. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:12pt"><B><I>Comment: </I></B>&nbsp;&nbsp;&nbsp;&nbsp;Please either confirm supplementally that shareholders of the Acquiring Fund will receive at least
60 days prior notice as required by Rule&nbsp;35d-1(a)(2) under the 1940 Act of the change to the Acquiring Fund&#146;s 80% non-fundamental investment policy regarding credit quality or revise the disclosure to accurately reflect the Acquiring
Fund&#146;s 80% investment policy. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:15%; font-size:12pt; font-family:Times New Roman" ALIGN="justify"><B><I>Response: </I></B>&nbsp;&nbsp;&nbsp;&nbsp;In accordance with
Rule 35d-1(a)(4), as a &#147;tax-exempt fund&#148; the Acquiring Fund has a fundamental policy to invest, under normal circumstances, at least 80% of its Managed Assets in municipal securities and other related investments the income from which is
exempt from regular federal income taxes. As disclosed in the Registration Statement (see, e.g., page 6), this policy will remain in place under the Acquiring Fund&#146;s new investment mandate. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:15%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">Given that the Acquiring Fund&#146;s fundamental policy regarding investment in municipal securities is not changing, the
Acquiring Fund does not believe Rule&nbsp;35d-1(a)(2) requires the provision to shareholders of 60 days prior notice of the change in its non-fundamental investment policies regarding credit quality. The Acquiring fund disseminated information
regarding these policy changes by press release dated August&nbsp;26, 2015. Additional information regarding these policy changes were posted to the website of the Acquiring Fund and will be included in the next shareholder report. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:12pt"><B><I>Comment: </I></B>&nbsp;&nbsp;&nbsp;&nbsp;In the second bullet in the Q&amp;A &#147;What are the anticipated benefits of the proposed
Reorganizations and the adoption of an expanded investment mandate of the combined fund?&#148; and elsewhere in the Registration Statement, please clarify whether the reference to &#147;[a] more attractive yield and risk profile versus other
national municipal closed-end funds in the marketplace&nbsp;.&nbsp;.&nbsp;.&#148; is intended to compare the Acquiring Fund to national municipal closed-end funds that invest in securities of any particular credit quality. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:15%; font-size:12pt; font-family:Times New Roman" ALIGN="justify"><B><I>Response: </I></B>&nbsp;&nbsp;&nbsp;&nbsp;In reviewing the proposed Reorganizations and investment policy changes, the
Board was given comparative information for funds investing in both investment-grade and lower-rated securities. However, the Registrant has revised the disclosure to remove the concept of comparing the combined fund&#146;s yield and
</P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g95583im3.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">U.S. Securities and Exchange Commission </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">October 19, 2015 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"> Page
 3
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:15%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">
risk profile to those of other national municipal closed-end funds in the marketplace. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:12pt"><B><I>Comment: </I></B>&nbsp;&nbsp;&nbsp;&nbsp;With reference to the Q&amp;A, &#147;What will happen if the required shareholder approvals are not
obtained?&#148; and similar statements elsewhere in the Registration Statement, please explain supplementally to the staff why the consent of the holders of VRDP Shares of Quality Income and Municipal Opportunity is not required in order for the
Reorganizations to occur. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:15%; font-size:12pt; font-family:Times New Roman" ALIGN="justify"><B><I>Response: </I></B>&nbsp;&nbsp;&nbsp;&nbsp;With respect to Quality
Income and Municipal Opportunity, the Agreement and Plan of Reorganization must be approved by a vote of each Fund&#146;s common shareholders and preferred shareholders, voting together as a single class, and by each Fund&#146;s preferred
shareholders, voting separately. In addition, the liquidity providers with respect to the VRDP Shares of Quality Income and Municipal Opportunity have certain consent rights pursuant the agreements governing the liquidity of the VRDP Shares. By
contrast, the outstanding VRDP Shares of the Acquiring Fund are operating pursuant to a special rate period and are not subject to a liquidity feature. Pursuant to the terms of the special rate period, the holder of such shares has certain consent
rights. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">(5)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:12pt"><B><I>Comment: </I></B>&nbsp;&nbsp;&nbsp;&nbsp;In the Notice of Special Meeting of Shareholders, please clarify that common shareholders of the
Acquiring Fund do not need to vote to approve Proposal No.&nbsp;1. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:15%; font-size:12pt; font-family:Times New Roman" ALIGN="justify"><B><I>Response:
</I></B>&nbsp;&nbsp;&nbsp;&nbsp;The Registrant has revised the disclosure in response to the staff&#146;s comment. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">(6)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:12pt"><B><I>Comment: </I></B>&nbsp;&nbsp;&nbsp;&nbsp;For the staff&#146;s information, please explain the legal basis for including the disclosure
captioned &#147;Important Note Regarding Forward-Looking Statements&#148; in the Registration Statement. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:15%; font-size:12pt; font-family:Times New Roman" ALIGN="justify"><B><I>Response: </I></B>&nbsp;&nbsp;&nbsp;&nbsp;The Registrant has removed the disclosure. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">(7)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:12pt"><B><I>Comment: </I></B>&nbsp;&nbsp;&nbsp;&nbsp;On page 10, under the caption &#147;Credit Quality,&#148; please prominently disclose that the
information provided for the Acquiring Fund does not reflect the Acquiring Fund&#146;s new investment mandate. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:15%; font-size:12pt; font-family:Times New Roman" ALIGN="justify"><B><I>Response: </I></B>&nbsp;&nbsp;&nbsp;&nbsp;The Registrant has revised the disclosure in response to the staff&#146;s
comment. </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g95583im3.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">U.S. Securities and Exchange Commission </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">October 19, 2015 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"> Page
 4
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">(8)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:12pt"><B><I>Comment: </I></B>&nbsp;&nbsp;&nbsp;&nbsp;On page 11, under the caption &#147;Leverage,&#148; please disclose whether the Acquiring
Fund&#146;s new investment mandate will impact the Acquiring Fund&#146;s use of leverage. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:15%; font-size:12pt; font-family:Times New Roman" ALIGN="justify"><B><I>Response: </I></B>&nbsp;&nbsp;&nbsp;&nbsp;The Registrant has revised the disclosure in response to the staff&#146;s
comment. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">(9)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:12pt"><B><I>Comment: </I></B>&nbsp;&nbsp;&nbsp;&nbsp;On page 14 of the Registration Statement, and elsewhere, please remove the reference to the new
fund-level fee schedule including a greater reduction in the fund-level management fee rate at $2 billion in assets under management. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:15%; font-size:12pt; font-family:Times New Roman" ALIGN="justify"><B><I>Response: </I></B>&nbsp;&nbsp;&nbsp;&nbsp;The Registrant has removed the disclosure in response to the staff&#146;s
comment. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">(10)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:12pt"><B><I>Comment: </I></B>&nbsp;&nbsp;&nbsp;&nbsp;Please revise the Comparative Fee Table and the Example to remove the effect of the fee waiver,
which provides varying levels of expense reduction during the period of its effectiveness. Also, for the staff&#146;s information, please explain supplementally how the weighted-average value of the fee waiver equals 0.05%. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:15%; font-size:12pt; font-family:Times New Roman" ALIGN="justify"><B><I>Response: </I></B>&nbsp;&nbsp;&nbsp;&nbsp;In response to the staff&#146;s comment, the Registrant has revised the
Comparative Fee Table and the Example to remove the effect of the fee waiver. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:15%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">For the information of the staff, and as
described in footnote&nbsp;6 to the Comparative Fee Table included in Amendment No.&nbsp;1, the fee waiver will provide varying levels of expense reduction during the one-year period it is in effect. The weighted average value of the fee waiver
during the one-year period during which it will be effective will be 0.03125% of <I>Managed Assets</I> (emphasis added). The fee table, however, is required to be presented as a percentage of assets attributable to common shares. The weighted
average value of the fee waiver, expressed as a percentage of assets attributable to common shares and rounded to the nearest basis point, is approximately 0.05%. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">(11)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:12pt"><B><I>Comment: </I></B>&nbsp;&nbsp;&nbsp;&nbsp;For the staff&#146;s information, please confirm whether the substantial revision of &#147;Tender
Option Bond Regulatory Risk&#148; and &#147;Inverse Floating Rate Securities Risk&#148; in the Risk Factors section indicates that the Acquiring Fund will increase its investments in such instruments following the Reorganizations and, if so, please
add disclosure in the Q&amp;A section and elsewhere in the document highlighting such increase. </P></TD></TR></TABLE>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g95583im3.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">U.S. Securities and Exchange Commission </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">October 19, 2015 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"> Page
 5
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:15%; font-size:12pt; font-family:Times New Roman" ALIGN="justify"><B><I>Response: </I></B>&nbsp;&nbsp;&nbsp;&nbsp;The revised disclosure
reflects standard changes across all of the Nuveen Funds as a result of changes in the TOB marketplace in response to the Volcker Rule. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">(12)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:12pt"><B><I>Comment: </I></B>&nbsp;&nbsp;&nbsp;&nbsp;On page 30, under the caption &#147;Multiple Series Risk,&#148; please add a cross reference
directing shareholders to the sections of the Joint Proxy Statement/Prospectus where the terms of the various preferred shares of the Funds are described. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:15%; font-size:12pt; font-family:Times New Roman" ALIGN="justify"><B><I>Response: </I></B>&nbsp;&nbsp;&nbsp;&nbsp;The Registrant has revised the disclosure in response to the staff&#146;s
comment. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">(13)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:12pt"><B><I>Comment: </I></B>&nbsp;&nbsp;&nbsp;&nbsp;On page 40, under the caption &#147;Terms of the Reorganizations,&#148; please remove the statement
to the effect that the summary of the Agreement is qualified in its entirety by reference to the full text of the Agreement attached to the Joint Proxy Statement/Prospectus as Appendix A. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:15%; font-size:12pt; font-family:Times New Roman" ALIGN="justify"><B><I>Response: </I></B>&nbsp;&nbsp;&nbsp;&nbsp;The Registrant has removed the disclosure in response to the staff&#146;s
comment. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">(14)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:12pt"><B><I>Comment: </I></B>&nbsp;&nbsp;&nbsp;&nbsp;On page 58, under the caption &#147;Description of VRDP Shares to Be Issued by the Acquiring
Fund,&#148; please review the revised fourth sentence in the second full paragraph to determine whether any revisions or clarifications may be necessary. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:15%; font-size:12pt; font-family:Times New Roman" ALIGN="justify"><B><I>Response: </I></B>&nbsp;&nbsp;&nbsp;&nbsp;The Registrant confirms that the revised sentence is accurate. However, the
Registrant has made certain minor revisions to add clarity to the disclosure in response to the staff&#146;s comment. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">(15)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:12pt"><B><I>Comment: </I></B>&nbsp;&nbsp;&nbsp;&nbsp;On page 104, under the caption &#147;Expenses of Proxy Solicitation,&#148; please disclose the costs
of the solicitation payable by the Funds. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:15%; font-size:12pt; font-family:Times New Roman" ALIGN="justify"><B><I>Response: </I></B>&nbsp;&nbsp;&nbsp;&nbsp;The
Registrant has revised the disclosure in response to the staff&#146;s comment. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">Please direct your questions and/or
comments regarding this filing to Deborah Bielicke Eades at (312)&nbsp;609-7661 or the undersigned at (312)&nbsp;609-7697. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:63%; font-size:12pt; font-family:Times New Roman">Very truly
yours, </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:63%; font-size:12pt; font-family:Times New Roman">/s/ Jacob C. Tiedt </P>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>g95583im1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g95583im1.jpg
M_]C_X  02D9)1@ ! 0$)8 E@  #_X@Q824-#7U!23T9)3$4  0$   Q(3&EN
M;P(0  !M;G1R4D="(%A96B 'S@ "  D !@ Q  !A8W-P35-&5     !)14,@
M<U)'0@                  ]M8  0    #3+4A0("
M                                             !%C<')T   !4
M #-D97-C   !A    &QW='!T   !\    !1B:W!T   "!    !1R6%E:   "
M&    !1G6%E:   "+    !1B6%E:   "0    !1D;6YD   "5    '!D;61D
M   "Q    (AV=65D   #3    (9V:65W   #U    "1L=6UI   #^    !1M
M96%S   $#    "1T96-H   $,     QR5%)#   $/   " QG5%)#   $/
M" QB5%)#   $/   " QT97AT     $-O<'ER:6=H=" H8RD@,3DY."!(97=L
M971T+5!A8VMA<F0@0V]M<&%N>0  9&5S8P         2<U)'0B!)14,V,3DV
M-BTR+C$              !)S4D="($E%0S8Q.38V+3(N,0
M                                                    6%E:(
M     /-1  $    !%LQ865H@                     %A96B        !O
MH@  ./4   .06%E:(        &*9  "WA0  &-I865H@        )*    ^$
M  "VSV1E<V,         %DE%0R!H='1P.B\O=W=W+FEE8RYC:
M    %DE%0R!H='1P.B\O=W=W+FEE8RYC:
M                                  !D97-C         "Y)14,@-C$Y
M-C8M,BXQ($1E9F%U;'0@4D="(&-O;&]U<B!S<&%C92 M('-21T(
M     "Y)14,@-C$Y-C8M,BXQ($1E9F%U;'0@4D="(&-O;&]U<B!S<&%C92 M
M('-21T(                             9&5S8P         L4F5F97)E
M;F-E(%9I97=I;F<@0V]N9&ET:6]N(&EN($E%0S8Q.38V+3(N,0
M    +%)E9F5R96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,V,3DV-BTR
M+C$                                  '9I97<      !.D_@ 47RX
M$,\4  /MS  $$PL  UR>     5A96B       $P)5@!0    5Q_G;65A<P
M       !                         H\    "<VEG(     !#4E0@8W5R
M=@        0     !0 *  \ %  9 !X (P H "T ,@ W #L 0 !% $H 3P!4
M %D 7@!C &@ ;0!R '< ? "! (8 BP"0 )4 F@"? *0 J0"N +( MP"\ ,$
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M])5?E<F6-):?EPJ7=9?@F$R8N)DDF9"9_)IHFM6;0INOG!R<B9SWG62=TIY
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M 2(  A$! Q$!_\0 'P   04! 0$! 0$           $" P0%!@<("0H+_\0
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)SS@>^>ZH$?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g95583im2.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g95583im2.jpg
M_]C_X  02D9)1@ ! 0$)8 E@  #_X@Q824-#7U!23T9)3$4  0$   Q(3&EN
M;P(0  !M;G1R4D="(%A96B 'S@ "  D !@ Q  !A8W-P35-&5     !)14,@
M<U)'0@                  ]M8  0    #3+4A0("
M                                             !%C<')T   !4
M #-D97-C   !A    &QW='!T   !\    !1B:W!T   "!    !1R6%E:   "
M&    !1G6%E:   "+    !1B6%E:   "0    !1D;6YD   "5    '!D;61D
M   "Q    (AV=65D   #3    (9V:65W   #U    "1L=6UI   #^    !1M
M96%S   $#    "1T96-H   $,     QR5%)#   $/   " QG5%)#   $/
M" QB5%)#   $/   " QT97AT     $-O<'ER:6=H=" H8RD@,3DY."!(97=L
M971T+5!A8VMA<F0@0V]M<&%N>0  9&5S8P         2<U)'0B!)14,V,3DV
M-BTR+C$              !)S4D="($E%0S8Q.38V+3(N,0
M                                                    6%E:(
M     /-1  $    !%LQ865H@                     %A96B        !O
MH@  ./4   .06%E:(        &*9  "WA0  &-I865H@        )*    ^$
M  "VSV1E<V,         %DE%0R!H='1P.B\O=W=W+FEE8RYC:
M    %DE%0R!H='1P.B\O=W=W+FEE8RYC:
M                                  !D97-C         "Y)14,@-C$Y
M-C8M,BXQ($1E9F%U;'0@4D="(&-O;&]U<B!S<&%C92 M('-21T(
M     "Y)14,@-C$Y-C8M,BXQ($1E9F%U;'0@4D="(&-O;&]U<B!S<&%C92 M
M('-21T(                             9&5S8P         L4F5F97)E
M;F-E(%9I97=I;F<@0V]N9&ET:6]N(&EN($E%0S8Q.38V+3(N,0
M    +%)E9F5R96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,V,3DV-BTR
M+C$                                  '9I97<      !.D_@ 47RX
M$,\4  /MS  $$PL  UR>     5A96B       $P)5@!0    5Q_G;65A<P
M       !                         H\    "<VEG(     !#4E0@8W5R
M=@        0     !0 *  \ %  9 !X (P H "T ,@ W #L 0 !% $H 3P!4
M %D 7@!C &@ ;0!R '< ? "! (8 BP"0 )4 F@"? *0 J0"N +( MP"\ ,$
MQ@#+ -  U0#; .  Y0#K /  ]@#[ 0$!!P$- 1,!&0$? 24!*P$R 3@!/@%%
M 4P!4@%9 6 !9P%N 74!? &# 8L!D@&: :$!J0&Q ;D!P0') =$!V0'A >D!
M\@'Z @,"# (4 AT")@(O C@"00)+ E0"70)G G$">@*$ HX"F *B JP"M@+!
M LL"U0+@ NL"]0,  PL#%@,A RT#. -# T\#6@-F W(#?@.* Y8#H@.N [H#
MQP/3 ^ #[ /Y! 8$$P0@!"T$.P1(!%4$8P1Q!'X$C 2:!*@$M@3$!-,$X03P
M!/X%#04<!2L%.@5)!5@%9P5W!88%E@6F!;4%Q075!>4%]@8&!A8&)P8W!D@&
M609J!GL&C :=!J\&P ;1!N,&]0<'!QD'*P<]!T\'80=T!X8'F0>L![\'T@?E
M!_@("P@?"#((1@A:"&X(@@B6"*H(O@C2".<(^PD0"24).@E/"60)>0F/":0)
MN@G/">4)^PH1"B<*/0I4"FH*@0J8"JX*Q0K<"O,+"PLB"SD+40MI"X +F NP
M"\@+X0OY#!(,*@Q##%P,=0R.#*<,P S9#/,-#0TF#4 -6@UT#8X-J0W##=X-
M^ X3#BX.20YD#G\.FPZV#M(.[@\)#R4/00]>#WH/E@^S#\\/[! )$"800Q!A
M$'X0FQ"Y$-<0]1$3$3$13Q%M$8P1JA')$>@2!Q(F$D429!*$$J,2PQ+C$P,3
M(Q-#$V,3@Q.D$\43Y10&%"<4211J%(L4K13.%/ 5$A4T%585>!6;%;T5X!8#
M%B86219L%H\6LA;6%OH7'1=!%V47B1>N%](7]Q@;&$ 891B*&*\8U1CZ&2 9
M11EK&9$9MQG=&@0:*AI1&G<:GAK%&NP;%!L[&V,;BANR&]H< APJ'%(<>QRC
M',P<]1T>'4<=<!V9'<,=[!X6'D >:AZ4'KX>Z1\3'SX?:1^4'[\?ZB 5($$@
M;""8(,0@\"$<(4@A=2&A(<XA^R(G(E4B@B*O(MTC"B,X(V8CE"/"(_ D'R1-
M)'PDJR3:)0DE."5H)9<EQR7W)B<F5R:')K<FZ"<8)TDG>B>K)]PH#2@_*'$H
MHBC4*08I."EK*9TIT"H"*C4J:"J;*L\K BLV*VDKG2O1+ 4L.2QN+*(LURT,
M+4$M=BVK+>$N%BY,+H(NMR[N+R0O6B^1+\<O_C U,&PPI##;,1(Q2C&",;HQ
M\C(J,F,RFS+4,PTS1C-_,[@S\30K-&4TGC38-1,U336'-<(U_38W-G(VKC;I
M-R0W8#><-]<X%#A0.(PXR#D%.4(Y?SF\.?DZ-CIT.K(Z[SLM.VL[JCOH/"<\
M93RD/.,](CUA/:$]X#X@/F ^H#[@/R$_83^B/^) (T!D0*9 YT$I06I!K$'N
M0C!"<D*U0O=#.D-]0\!$ T1'1(I$SD42155%FD7>1B)&9T:K1O!'-4=[1\!(
M!4A+2)%(UTD=26-)J4GP2C=*?4K$2PQ+4TN:2^),*DQR3+I- DU*39--W$XE
M3FY.MT\ 3TE/DT_=4"=0<5"[40914%&;4>92,5)\4L=3$U-?4ZI3]E1"5(]4
MVU4H5755PE8/5EQ6J5;W5T17DE?@6"]8?5C+61I9:5FX6@=:5EJF6O5;15N5
M6^5<-5R&7-9=)UUX7<E>&EYL7KU?#U]A7[-@!6!78*I@_&%/8:)A]6))8IQB
M\&-#8Y=CZV1 9)1DZ64]99)EYV8]9I)FZ&<]9Y-GZ6@_:)9H[&E#:9II\6I(
M:I]J]VM/:Z=K_VQ7;*]M"&U@;;EN$FYK;L1O'F]X;]%P*W"&<.!Q.G&5<?!R
M2W*F<P%S77.X=!1T<'3,=2AUA77A=CYVFW;X=U9WLW@1>&YXS'DJ>8EYYWI&
M>J5[!'MC>\)\(7R!?.%]07VA?@%^8G["?R-_A'_E@$> J($*@6N!S8(P@I*"
M](-7@[J$'82 A..%1X6KA@Z&<H;7ASN'GX@$B&F(SHDSB9F)_HIDBLJ+,(N6
MB_R,8XS*C3&-F(W_CF:.SH\VCYZ0!I!ND-:1/Y&HDA&2>I+CDTV3MI0@E(J4
M])5?E<F6-):?EPJ7=9?@F$R8N)DDF9"9_)IHFM6;0INOG!R<B9SWG62=TIY
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M 2(  A$! Q$!_\0 'P   04! 0$! 0$           $" P0%!@<("0H+_\0
MM1   @$# P($ P4%! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*Q
MP152T? D,V)R@@D*%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA9
M6F-D969G:&EJ<W1U=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*S
MM+6VM[BYNL+#Q,7&Q\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ
M_\0 'P$  P$! 0$! 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#
M! <%! 0  0)W  $" Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1
M"A8D-.$E\1<8&1HF)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI
M:G-T=79W>'EZ@H.$A8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZ
MPL/$Q<;'R,G*TM/4U=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1
M Q$ /P#],/''B?4O"FEQ76A>&-7\53R3"-K33)8$DC7!.\F:1%QP!P<\CBN(
M_P"%S>+O^B->//\ P-TS_P"2J]:HH \E_P"%S>+O^B->//\ P-TS_P"2J/\
MA<WB[_HC7CS_ ,#=,_\ DJO6J* /)?\ A<WB[_HC7CS_ ,#=,_\ DJC_ (7-
MXN_Z(UX\_P# W3/_ )*KUJB@#R7_ (7-XN_Z(UX\_P# W3/_ )*H_P"%S>+O
M^B->//\ P-TS_P"2J]:HH \E_P"%S>+O^B->//\ P-TS_P"2J/\ A<WB[_HC
M7CS_ ,#=,_\ DJO6J* /)?\ A<WB[_HC7CS_ ,#=,_\ DJC_ (7-XN_Z(UX\
M_P# W3/_ )*KUJB@#R7_ (7-XN_Z(UX\_P# W3/_ )*H_P"%S>+O^B->//\
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M_P"%S>+O^B->//\ P-TS_P"2J/\ A<WB[_HC7CS_ ,#=,_\ DJO6J* /)?\
MA<WB[_HC7CS_ ,#=,_\ DJC_ (7-XN_Z(UX\_P# W3/_ )*KUJB@#R7_ (7-
MXN_Z(UX\_P# W3/_ )*H_P"%S>+O^B->//\ P-TS_P"2J]:HH \E_P"%S>+O
M^B->//\ P-TS_P"2J/\ A<WB[_HC7CS_ ,#=,_\ DJO6J* /)?\ A<WB[_HC
M7CS_ ,#=,_\ DJC_ (7-XN_Z(UX\_P# W3/_ )*KUJB@#R7_ (7-XN_Z(UX\
M_P# W3/_ )*H_P"%S>+O^B->//\ P-TS_P"2J]:HH \E_P"%S>+O^B->//\
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M ,#=,_\ DJO6J* /)?\ A<WB[_HC7CS_ ,#=,_\ DJC_ (7-XN_Z(UX\_P#
MW3/_ )*KUJB@#R7_ (7-XN_Z(UX\_P# W3/_ )*H_P"%S>+O^B->//\ P-TS
M_P"2J]:HH \E_P"%S>+O^B->//\ P-TS_P"2J/\ A<WB[_HC7CS_ ,#=,_\
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M<W"6DR2R>6$W\+NY^0AOH<]*E\,Z)<Z*U_8M;Z3;:'$8DTRWLH/+.WRQYK2
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M-9-(MYJ^F0&*80R"6[C79(1D(<GAL<XZT+XETY)C%>7=I:2-=FTA2:ZB!GD
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
K%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>g95583im3.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g95583im3.jpg
M_]C_X  02D9)1@ ! 0$)8 E@  #_X@Q824-#7U!23T9)3$4  0$   Q(3&EN
M;P(0  !M;G1R4D="(%A96B 'S@ "  D !@ Q  !A8W-P35-&5     !)14,@
M<U)'0@                  ]M8  0    #3+4A0("
M                                             !%C<')T   !4
M #-D97-C   !A    &QW='!T   !\    !1B:W!T   "!    !1R6%E:   "
M&    !1G6%E:   "+    !1B6%E:   "0    !1D;6YD   "5    '!D;61D
M   "Q    (AV=65D   #3    (9V:65W   #U    "1L=6UI   #^    !1M
M96%S   $#    "1T96-H   $,     QR5%)#   $/   " QG5%)#   $/
M" QB5%)#   $/   " QT97AT     $-O<'ER:6=H=" H8RD@,3DY."!(97=L
M971T+5!A8VMA<F0@0V]M<&%N>0  9&5S8P         2<U)'0B!)14,V,3DV
M-BTR+C$              !)S4D="($E%0S8Q.38V+3(N,0
M                                                    6%E:(
M     /-1  $    !%LQ865H@                     %A96B        !O
MH@  ./4   .06%E:(        &*9  "WA0  &-I865H@        )*    ^$
M  "VSV1E<V,         %DE%0R!H='1P.B\O=W=W+FEE8RYC:
M    %DE%0R!H='1P.B\O=W=W+FEE8RYC:
M                                  !D97-C         "Y)14,@-C$Y
M-C8M,BXQ($1E9F%U;'0@4D="(&-O;&]U<B!S<&%C92 M('-21T(
M     "Y)14,@-C$Y-C8M,BXQ($1E9F%U;'0@4D="(&-O;&]U<B!S<&%C92 M
M('-21T(                             9&5S8P         L4F5F97)E
M;F-E(%9I97=I;F<@0V]N9&ET:6]N(&EN($E%0S8Q.38V+3(N,0
M    +%)E9F5R96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,V,3DV-BTR
M+C$                                  '9I97<      !.D_@ 47RX
M$,\4  /MS  $$PL  UR>     5A96B       $P)5@!0    5Q_G;65A<P
M       !                         H\    "<VEG(     !#4E0@8W5R
M=@        0     !0 *  \ %  9 !X (P H "T ,@ W #L 0 !% $H 3P!4
M %D 7@!C &@ ;0!R '< ? "! (8 BP"0 )4 F@"? *0 J0"N +( MP"\ ,$
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M])5?E<F6-):?EPJ7=9?@F$R8N)DDF9"9_)IHFM6;0INOG!R<B9SWG62=TIY
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M 2(  A$! Q$!_\0 'P   04! 0$! 0$           $" P0%!@<("0H+_\0
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@K*WN8P52XB610>H##/\ 6I)(DE7;*BNOHPR*?TH _]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
